Free Trial

InnovAge (NASDAQ:INNV) Stock Price Down 0.3% - Time to Sell?

InnovAge logo with Medical background
Remove Ads

InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report)'s stock price was down 0.3% during trading on Monday . The stock traded as low as $3.33 and last traded at $3.48. Approximately 68,711 shares changed hands during mid-day trading, an increase of 50% from the average daily volume of 45,724 shares. The stock had previously closed at $3.49.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. reaffirmed an "underweight" rating and issued a $5.00 target price on shares of InnovAge in a research note on Tuesday, December 17th.

Read Our Latest Research Report on INNV

InnovAge Price Performance

The firm has a market cap of $435.49 million, a price-to-earnings ratio of -16.95 and a beta of 0.39. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.27. The stock's fifty day moving average price is $3.52 and its 200-day moving average price is $4.74.

InnovAge (NASDAQ:INNV - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.10) EPS for the quarter. InnovAge had a negative net margin of 3.19% and a negative return on equity of 9.45%. As a group, equities research analysts forecast that InnovAge Holding Corp. will post -0.12 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC purchased a new position in shares of InnovAge during the 4th quarter worth approximately $43,000. Squarepoint Ops LLC purchased a new position in shares of InnovAge during the fourth quarter worth $68,000. Bank of America Corp DE grew its stake in shares of InnovAge by 42.4% in the fourth quarter. Bank of America Corp DE now owns 19,945 shares of the company's stock valued at $78,000 after buying an additional 5,936 shares in the last quarter. Barclays PLC raised its holdings in shares of InnovAge by 13.6% in the 4th quarter. Barclays PLC now owns 29,099 shares of the company's stock valued at $115,000 after buying an additional 3,485 shares during the period. Finally, BNP Paribas Financial Markets purchased a new position in InnovAge during the 4th quarter valued at about $123,000. Hedge funds and other institutional investors own 12.26% of the company's stock.

Remove Ads

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Further Reading

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads